Nivalis Therapeutics, Inc. (NVLS) - NASDAQ
Company Description
Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company which engages in discovery, development and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance... More
Sector: Healthcare
Industry: Biotechnology
Country: United States